Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver S Chow

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The Annals of Thoracic Surgery|July 3, 2020
Early Infant Symptomatic Patients With Tetralogy of Fallot With Absent Pulmonary Valve: Pulmonary Artery Management and Airway StabilizationOliver S Chow, David M Hoganson, Aditya K Kaza, et al.
Genes, Chromosomes & Cancer|February 12, 2016
Integrated genomic profiling identifies microRNA-92a regulation of IQGAP2 in locally advanced rectal cancerRaphael Pelossof, Oliver S Chow, Lauren Fairchild, et al.
Cancers|October 16, 2024
Epidemiological Study of Adenoid Cystic Carcinoma and Its Outcomes: Insights from the Surveillance, Epidemiology, and End Results (SEER) DatabaseMohamed Rahouma, Sherif Khairallah, Massimo Baudo, et al.
BMC Cancer|October 27, 2015
Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative managementJ Joshua Smith, Oliver S Chow, Marc J Gollub, et al.
Annals of Surgical Oncology|March 30, 2016
KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant TherapyOliver S Chow, Deborah Kuk, Metin Keskin, et al.
The Lancet. Oncology|July 19, 2015
Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trialJulio Garcia-Aguilar, Oliver S Chow, David D Smith, et al.
The Lancet. Oncology|October 18, 2015
Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trialJulio Garcia-Aguilar, Lindsay A Renfro, Oliver S Chow, et al.
JAMA Oncology|January 11, 2019
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant TherapyJ Joshua Smith, Paul Strombom, Oliver S Chow, et al.
Nature Medicine|August 15, 2022
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancerWalid K Chatila, Jin K Kim, Henry Walch, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Annals of Thoracic Surgery|July 3, 2020
Early Infant Symptomatic Patients With Tetralogy of Fallot With Absent Pulmonary Valve: Pulmonary Artery Management and Airway StabilizationOliver S Chow, David M Hoganson, Aditya K Kaza, et al.
Genes, Chromosomes & Cancer|February 12, 2016
Integrated genomic profiling identifies microRNA-92a regulation of IQGAP2 in locally advanced rectal cancerRaphael Pelossof, Oliver S Chow, Lauren Fairchild, et al.
Cancers|October 16, 2024
Epidemiological Study of Adenoid Cystic Carcinoma and Its Outcomes: Insights from the Surveillance, Epidemiology, and End Results (SEER) DatabaseMohamed Rahouma, Sherif Khairallah, Massimo Baudo, et al.
BMC Cancer|October 27, 2015
Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative managementJ Joshua Smith, Oliver S Chow, Marc J Gollub, et al.
Annals of Surgical Oncology|March 30, 2016
KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant TherapyOliver S Chow, Deborah Kuk, Metin Keskin, et al.
The Lancet. Oncology|July 19, 2015
Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trialJulio Garcia-Aguilar, Oliver S Chow, David D Smith, et al.
The Lancet. Oncology|October 18, 2015
Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trialJulio Garcia-Aguilar, Lindsay A Renfro, Oliver S Chow, et al.
JAMA Oncology|January 11, 2019
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant TherapyJ Joshua Smith, Paul Strombom, Oliver S Chow, et al.
Nature Medicine|August 15, 2022
Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancerWalid K Chatila, Jin K Kim, Henry Walch, et al.
Pageof 2